President Donald Trump claims that the US FDA and the Democratic party deliberately delayed the announcement of the Pfizer COVID-19 trial and subsequently marred his reelection campaign.
Pfizer announced Monday that their first set of results from Phase 3 COVID-19 vaccine trial achieved 90% efficacy rate, 7 days after the second dose.
Trump made the accusation after tweets that the COVID-19 vaccine has been authorized for release in late November. It was developed by Pfizer in cooperation with BioNTech.
The FDA requires that pharmaceutical firms study the effects of vaccines on at least 30,000 test subjects, including the elderly and other high-risk individuals.
Pfizer released a statement in July announcing that they were part of Operation Warp Speed, the Trump administration’s plan to accelerate the production of the coronavirus.
According to Kathrin Jansen, senior vice president and head of vaccine research and development, “Pfizer did reach an advanced purchase agreement with the U.S. government.”
Pfizer was promised almost $2 billion in funding however, “the company did not accept BARDA funding for the research and development process” and that “the investment for R&D and manufacturing has been made by Pfizer at risk.”
If the Pfizer trial schedule holds true, and the vaccine is ready for the public use by November, it will still take some time for the production of enough doses for millions of people.